FDA rejects first needle-free alternative to EpiPens, calling for additional research

By NBC News
| September 20, 2023

The move came as a surprise: In May, an FDA advisory committee voted to recommend approval of the drug for children and adults.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

One of the most important elements of a company’s success is also one of the least tangible —culture. ...